European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC

Amr Abdin¹, Chris Wilkinson^{2

3}, Suleman Aktaa^{4

5

6}, Michael Böhm¹, Marija Polovina⁷, Giuseppe Rosano^{8

9}, Mitja Lainscak^{10

11}, Lars H Lund¹², Theresa McDonagh^{13

14}, Marco Metra¹⁵, Marianna Adamo¹⁵, Richard Mindham¹⁶, Massimo Piepoli^{17

18}, Magdy Abdelhamid¹⁹, Stefan Störk²⁰, Maria P Tokmakova²¹, Petar Seferović⁷, Andrew J S Coats²², Chris P Gale^{4

5

6}

Affiliations

¹ Internal Medicine Clinic III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
² Hull York Medical School, University of York, York, UK.
³ Academic Cardiovascular Unit, South Tees NHS Foundation Trust, James Cook University Hospital, Middlesbrough, UK.
⁴ Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
⁵ Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
⁶ Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁷ Serbian Academy of Sciences and Arts, University of Belgrade Faculty of Medicine and Heart Failure Center, Belgrade University Medical Center, Belgrade, Serbia.
⁸ Department of Cardiology, St George's University and St George's University Hospitals, London, UK.
⁹ Department of Cardiology, San Raffaele Cassino Hospital, Cassino, Italy.
¹⁰ Department of Internal Medicine, and Department of Research and Education, General Hospital Murska Sobota, Murska Sobota, Slovenia.
¹¹ Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
¹² Department of Medicine Karolinska Institute, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
¹³ King's College Hospital, London, UK.
¹⁴ School of Cardiovascular Medicine & Sciences, King's College London, London, UK.
¹⁵ Cardiology, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
¹⁶ ESC Patient Forum, Sophia Antipolis, France.
¹⁷ Clinical Cardiology, IRCCS Policlinico San Donato, Milan, Italy.
¹⁸ Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
¹⁹ Faculty of Medicine, Kasr Al Ainy, Cardiology Department, Cairo University, Giza, Egypt.
²⁰ Department of Clinical Research & Epidemiology, Comprehensive Heart Failure Centre and Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
²¹ Department of Cardiology, Medical University of Plovdiv, Plovdiv, Bulgaria.
²² Heart Research Institute, Sydney, Australia.

PMID: 38995217
DOI: 10.1002/ejhf.3376

Free article

Review

European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC

Amr Abdin et al. Eur J Heart Fail. 2024 Sep.

Free article

. 2024 Sep;26(9):1867-1875.

doi: 10.1002/ejhf.3376. Epub 2024 Jul 12.

Authors

Affiliations

¹ Internal Medicine Clinic III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
² Hull York Medical School, University of York, York, UK.
³ Academic Cardiovascular Unit, South Tees NHS Foundation Trust, James Cook University Hospital, Middlesbrough, UK.
⁴ Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
⁵ Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
⁶ Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁷ Serbian Academy of Sciences and Arts, University of Belgrade Faculty of Medicine and Heart Failure Center, Belgrade University Medical Center, Belgrade, Serbia.
⁸ Department of Cardiology, St George's University and St George's University Hospitals, London, UK.
⁹ Department of Cardiology, San Raffaele Cassino Hospital, Cassino, Italy.
¹⁰ Department of Internal Medicine, and Department of Research and Education, General Hospital Murska Sobota, Murska Sobota, Slovenia.
¹¹ Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
¹² Department of Medicine Karolinska Institute, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
¹³ King's College Hospital, London, UK.
¹⁴ School of Cardiovascular Medicine & Sciences, King's College London, London, UK.
¹⁵ Cardiology, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
¹⁶ ESC Patient Forum, Sophia Antipolis, France.
¹⁷ Clinical Cardiology, IRCCS Policlinico San Donato, Milan, Italy.
¹⁸ Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
¹⁹ Faculty of Medicine, Kasr Al Ainy, Cardiology Department, Cairo University, Giza, Egypt.
²⁰ Department of Clinical Research & Epidemiology, Comprehensive Heart Failure Centre and Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
²¹ Department of Cardiology, Medical University of Plovdiv, Plovdiv, Bulgaria.
²² Heart Research Institute, Sydney, Australia.

PMID: 38995217
DOI: 10.1002/ejhf.3376

Abstract

Aims: To update the European Society of Cardiology (ESC) quality indicators (QIs) for the evaluation of the care and outcomes of adults with heart failure.

Methods and results: The Working Group comprised experts in heart failure including members of the ESC Clinical Practice Guidelines Task Force for heart failure, members of the Heart Failure Association, and a patient representative. We followed the ESC methodology for QI development. The 2023 focused guideline update was reviewed to assess the suitability of the recommendations with strongest association with benefit and harm against the ESC criteria for QIs. All the new proposed QIs were individually graded by each panellist via online questionnaires for both validity and feasibility. The existing heart failure QIs also underwent voting to 'keep', 'remove' or 'modify'. Five domains of care for the management of heart failure were identified: (1) structural QIs, (2) patient assessment, (3) initial treatment, (4) therapy optimization, and (5) patient health-related quality of life. In total, 14 'main' and 3 'secondary' QIs were selected across the five domains.

Conclusion: This document provides an update of the previously published ESC QIs for heart failure to ensure that these measures are aligned with contemporary evidence. The QIs may be used to quantify adherence to clinical practice as recommended in guidelines to improve the care and outcomes of patients with heart failure.

Keywords: Clinical practice guidelines; Heart failure; Outcomes; Quality indicators.

PubMed Disclaimer

References

1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
1. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al.; EMPEROR‐Preserved Trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021;385:1451–1461. https://doi.org/10.1056/NEJMoa2107038
1. Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al.; DELIVER Trial Committees and Investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022;387:1089–1098. https://doi.org/10.1056/NEJMoa2206286
1. Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, et al. SGLT‐2 inhibitors in patients with heart failure: A comprehensive meta‐analysis of five randomised controlled trials. Lancet 2022;400:757–767. https://doi.org/10.1016/S0140‐6736(22)01429‐5
1. Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, et al.; IRONMAN Study Group. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator‐initiated, prospective, randomised, open‐label, blinded‐endpoint trial. Lancet 2022;400:2199–2209. https://doi.org/10.1016/S0140‐6736(22)02083‐9

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC

Affiliations

European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical